USPTO serial 79105465
FROM CELLS TO THERAPEUTICS VIVALIS
Reviewed by CopyMark Law Group
Reg. 4287225Status 404
- Filing date
- Status date
- Registration date
- Feb 12, 2013
- Examiner
- COLEMAN, CIMMERIAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FROM CELLS TO THERAPEUTICS VIVALIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-49450 Roussay, FR
F-49450 Roussay, FR
F-49450 Roussay, FR
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Molecules obtained from biotechnologies, proteins, biotechnological products for research and diagnosis; proteins in raw material form for scientific and medical research; micro-organisms, namely, cultures of micro-organisms other than for medical and veterinary use; cells, avian embryonic stem cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for research and diagnosis, all these products being not for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary purposes; bacteriological preparations for use in cell cultures other than for medical and veterinary use | SECTION 71 - CANCELLED | — |
| 005 | Prophylactic and therapeutic medicines, pharmaceutical and veterinary medicines, namely, medical, biological, biotechnological and/or genetic technology preparations and products for medical, pharmaceutical or veterinary use for the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; micro-organisms, cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for therapy and diagnosis, all for medical use; molecules and antibodies for medical or pharmaceutical use; biotechnological products for medical or pharmaceutical use, namely, for use in the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; diagnosis products for medical or pharmaceutical use, namely, prophylactic and therapeutic vaccines, none relating to sexual health | SECTION 71 - CANCELLED | — |
| 042 | Scientific services, namely, scientific research; research and development of new products or process for production and/or purification of biological products for third parties; biological research and research in the fields of bacteriology, virology, immunology, biotechnology, genetics, medicine, pharmacology, and scientific research services for medical purposes; scientific research services for pharmaceutical purposes and scientific research services for veterinary purposes; development of technologies and scientific and industrial research to obtain and prepare cells, cell lines, and to produce and/or purify proteins, viruses, human and animal material | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VIVALIS
- Other trademarks owned by VIVALIS
- Other trademarks owned by VIVALIS
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named FROM CELLS TO THERAPEUTICS VIVALIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 19, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 17, 2020 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 16, 2020 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 16, 2020 | INPC | INVALIDATION PROCESSED | — |
| May 13, 2020 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 13, 2019 | C71T | CANCELLED SECTION 71 | — |
| Mar 19, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 12, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 2, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 14, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 14, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 12, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 19, 2013 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 6, 2013 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Mar 2, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 12, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 21, 2012 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 27, 2012 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Oct 24, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 15, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 14, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 4, 2012 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 7, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 7, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 27, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 18, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 18, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 18, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 3, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 28, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 28, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2012 | ALIE | ASSIGNED TO LIE | — |
| Jun 5, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 9, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 21, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 21, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 20, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 19, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 13, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 9, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 8, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |